Hoffmann - La Roche - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups by Category

All Categories ... by Company » ... Hoffmann - La Roche

A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive

Condition: Hepatitis B, Chronic
Interventions: Drug: peginterferon alfa-2a [PEGASYS]; Drug: peginterferon alfa-2a [PEGASYS]; Drug: Adefovir
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified March 2010
A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

Condition: Chronic Hepatitis C
Interventions: Drug: peginterferon alfa-2a [Pegasys]; Device: autoinjector; Device: pre-filled syringe
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified March 2010
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

Condition: Healthy Volunteers
Intervention: Drug: Mycophenolate Mofetil Capsule 250 mg
Sponsor: Panacea Biotec Ltd
Completed - verified March 2010
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

Condition: Healthy Volunteers
Intervention: Drug: Mycophenolate Mofetil Capsule 250 mg
Sponsor: Panacea Biotec Ltd
Completed - verified March 2010
Erlotinib in Hegher Risk Myelodysplastic Syndrome

Condition: Myelodysplastic Syndrome
Intervention: Drug: Erlotinib
Sponsors: Groupe Francophone des Myelodysplasies; Roche Pharma AG
Active, not recruiting - verified March 2010
A Study of Avastin (Bevacizumab) With XELOX in Patients With Colorectal Cancer and Disease Progression on FOLFIRI and Avastin.

Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: capecitabine [Xeloda]; Drug: oxaliplatin
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)

Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
An Observational Study on The Safety and Effectiveness of Mabthera (Rituximab) in The First Six Months of Treatment in Patients With Severe Active Rheumatoid Arthritis

Condition: Severe Active Rheumatoid Arthritis According to the Current SPC
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer

Condition: Non-small Cell Lung Cancer
Interventions: Drug: RO4929097; Drug: RO4929097
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Cohort Study in Type 2 Diabetes in China

Condition: Type 2 Diabetes
Intervention:
Sponsors: China Cardiometabolic Registries; Roche Pharma AG; VitalStrategic Research Institute; Chinese College of Cardiovascular Physicians; China Endocrinologist Association
Not yet recruiting - verified February 2010
A Study of Avastin (Bevacizumab) With XELOX in Patients With Colorectal Cancer and Disease Progression on FOLFIRI and Avastin

Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: capecitabine [Xeloda]; Drug: oxaliplatin
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer

Condition: Colorectal Cancer
Interventions: Drug: BVZ+XELOX or BVZ+XELIRI or BVZ+FUIRI or BVZ+FUOX; Drug: BVZ+XELOX
Sponsors: Spanish Cooperative Group for Gastrointestinal Tumour Therapy; Hoffmann-La Roche
Not yet recruiting - verified February 2010

Hoffmann - La Roche - Database of Clinical Trials by Pharmaceutical Companies - Clinical Trials

Hoffmann - La Roche - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups by Category

Main Menu

Find Clinical Trials

Clinical Trial Locations

Clinical Trial Categories

Patient Recruiting...

Paid Clinical Trials